10-Q Filing

CENCORA, INC. CIK: 1140859 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0001140859-21-000025`
Period End Date	20210331
Filing Date	20210505
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	abc-20210331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 84 Cash Flow Statement 78 Stockholders Equity 48 Comprehensive Income 28

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Allowances for returns and credit losses	`AllowancesForReturnsAndDoubtfulAccounts`	$1.42B	USD	Point-in-time
Allowances for returns and credit losses	`AllowancesForReturnsAndDoubtfulAccounts`	$1.32B	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, authorized (shares)	`CommonStockSharesAuthorized`	600.00M	shares	Point-in-time
Cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.69B	USD	Point-in-time
Cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.60B	USD	Point-in-time
Common stock, authorized (shares)	`CommonStockSharesAuthorized`	600.00M	shares	Point-in-time
Cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.37B	USD	Point-in-time
Cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.64B	USD	Point-in-time
Accounts receivable, less allowances for returns and credit losses: $1,318,643 as of March 31, 2021 and $1,417,308 as of September 30, 2020	`AccountsReceivableNetCurrent`	$14.13B	USD	Point-in-time
Common stock, issued (shares)	`CommonStockSharesIssued`	287.79M	shares	Point-in-time
Accounts receivable, less allowances for returns and credit losses: $1,318,643 as of March 31, 2021 and $1,417,308 as of September 30, 2020	`AccountsReceivableNetCurrent`	$13.85B	USD	Point-in-time
Common stock, issued (shares)	`CommonStockSharesIssued`	289.96M	shares	Point-in-time
Common stock, outstanding (shares)	`CommonStockSharesOutstanding`	204.23M	shares	Point-in-time
Inventories	`InventoryNet`	$12.95B	USD	Point-in-time
Inventories	`InventoryNet`	$12.59B	USD	Point-in-time
Common stock, outstanding (shares)	`CommonStockSharesOutstanding`	205.33M	shares	Point-in-time
Right to recover assets	`ContractWithCustomerAssetGrossCurrent`	$1.22B	USD	Point-in-time
Right to recover assets	`ContractWithCustomerAssetGrossCurrent`	$1.34B	USD	Point-in-time
Treasury stock (shares)	`TreasuryStockShares`	83.56M	shares	Point-in-time
Treasury stock (shares)	`TreasuryStockShares`	84.63M	shares	Point-in-time
Income tax receivable	`IncomeTaxesReceivable`	$488.43M	USD	Point-in-time
Income tax receivable	`IncomeTaxesReceivable`	$331.29M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$189.30M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$190.64M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$35.47B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$33.06B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.48B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.48B	USD	Point-in-time
Goodwill	`Goodwill`	$6.71B	USD	Point-in-time
Goodwill	`Goodwill`	$6.71B	USD	Point-in-time
Other intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$1.89B	USD	Point-in-time
Other intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$1.84B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$361.64M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$302.55M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.20B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$779.85M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$44.27B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$47.00B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$31.42B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$31.71B	USD	Point-in-time
Accrued expenses and other	`AccruedLiabilitiesCurrent`	$1.53B	USD	Point-in-time
Accrued expenses and other	`AccruedLiabilitiesCurrent`	$1.65B	USD	Point-in-time
Short-term debt	`DebtCurrent`	$501.26M	USD	Point-in-time
Short-term debt	`DebtCurrent`	$43.88M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$33.85B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$33.00B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$6.15B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$3.62B	USD	Point-in-time
Accrued income taxes	`AccruedIncomeTaxesNoncurrent`	$273.03M	USD	Point-in-time
Accrued income taxes	`AccruedIncomeTaxesNoncurrent`	$284.85M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$686.49M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$768.55M	USD	Point-in-time
Accrued litigation liability	`LitigationReserveNoncurrent`	$6.20B	USD	Point-in-time
Accrued litigation liability	`LitigationReserveNoncurrent`	$6.21B	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$708.17M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$472.86M	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value - authorized, issued, and outstanding: 600,000,000 shares, 289,959,239 shares, and 205,326,154 shares as of March 31, 2021, respectively, and 600,000,000 shares, 287,790,479 shares, and 204,226,465 shares as of September 30, 2020, respectively	`CommonStockValue`	$2.88M	USD	Point-in-time
Common stock, $0.01 par value - authorized, issued, and outstanding: 600,000,000 shares, 289,959,239 shares, and 205,326,154 shares as of March 31, 2021, respectively, and 600,000,000 shares, 287,790,479 shares, and 204,226,465 shares as of September 30, 2020, respectively	`CommonStockValue`	$2.90M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$5.08B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$5.28B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.12B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$518.34M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-69.25M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-108.83M	USD	Point-in-time
Treasury stock, at cost: 84,633,085 shares as of March 31, 2021 and 83,564,014 shares as of September 30, 2020	`TreasuryStockValue`	$6.51B	USD	Point-in-time
Treasury stock, at cost: 84,633,085 shares as of March 31, 2021 and 83,564,014 shares as of September 30, 2020	`TreasuryStockValue`	$6.62B	USD	Point-in-time
Total AmerisourceBergen Corporation stockholders' deficit	`StockholdersEquity`	$-1.02B	USD	Point-in-time
Total AmerisourceBergen Corporation stockholders' deficit	`StockholdersEquity`	$-281.76M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$179.29M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$178.97M	USD	Point-in-time
Total deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.07B	USD	Point-in-time
Total deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-839.64M	USD	Point-in-time
Total deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.99B	USD	Point-in-time
Total deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.71B	USD	Point-in-time
Total deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-102.78M	USD	Point-in-time
Total deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-511.55M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT	`LiabilitiesAndStockholdersEquity`	$47.00B	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT	`LiabilitiesAndStockholdersEquity`	$44.27B	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$49.15B	USD	1 Quarter
Revenue	`Revenues`	$47.42B	USD	1 Quarter
Revenue	`Revenues`	$101.67B	USD	2 Qtrs
Revenue	`Revenues`	$95.28B	USD	2 Qtrs
Cost of goods sold	`CostOfGoodsAndServicesSold`	$98.69B	USD	2 Qtrs
Cost of goods sold	`CostOfGoodsAndServicesSold`	$47.62B	USD	1 Quarter
Cost of goods sold	`CostOfGoodsAndServicesSold`	$46.03B	USD	1 Quarter
Cost of goods sold	`CostOfGoodsAndServicesSold`	$92.66B	USD	2 Qtrs
Gross profit	`GrossProfit`	$2.99B	USD	2 Qtrs
Gross profit	`GrossProfit`	$1.53B	USD	1 Quarter
Gross profit	`GrossProfit`	$2.62B	USD	2 Qtrs
Gross profit	`GrossProfit`	$1.39B	USD	1 Quarter
Distribution, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$693.41M	USD	1 Quarter
Distribution, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$1.47B	USD	2 Qtrs
Distribution, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$730.08M	USD	1 Quarter
Distribution, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$1.38B	USD	2 Qtrs
Depreciation	`DepreciationNonproduction`	$149.22M	USD	2 Qtrs
Depreciation	`DepreciationNonproduction`	$139.04M	USD	2 Qtrs
Depreciation	`DepreciationNonproduction`	$69.80M	USD	1 Quarter
Depreciation	`DepreciationNonproduction`	$75.27M	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$51.13M	USD	2 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$24.00M	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$25.53M	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$59.27M	USD	2 Qtrs
Employee severance, litigation, and other	`RestructuringCharges`	$107.04M	USD	2 Qtrs
Employee severance, litigation, and other	`RestructuringCharges`	$148.54M	USD	2 Qtrs
Employee severance, litigation, and other	`RestructuringCharges`	$67.73M	USD	1 Quarter
Employee severance, litigation, and other	`RestructuringCharges`	$78.16M	USD	1 Quarter
Impairment of PharMEDium assets	`AssetImpairmentCharges`	-	USD	2 Qtrs
Impairment of PharMEDium assets	`AssetImpairmentCharges`	$361.65M	USD	2 Qtrs
Impairment of PharMEDium assets	`AssetImpairmentCharges`	-	USD	1 Quarter
Impairment of PharMEDium assets	`AssetImpairmentCharges`	$223.65M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$1.17B	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$624.35M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$572.95M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$309.51M	USD	1 Quarter
Other loss (income), net	`NonoperatingIncomeExpense`	$1.11M	USD	1 Quarter
Other loss (income), net	`NonoperatingIncomeExpense`	$-23.31M	USD	1 Quarter
Other loss (income), net	`NonoperatingIncomeExpense`	$-9.04M	USD	2 Qtrs
Other loss (income), net	`NonoperatingIncomeExpense`	$-1.73M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-34.53M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-34.42M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-68.14M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-65.43M	USD	2 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$505.79M	USD	2 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$566.51M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.09B	USD	2 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$276.20M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$281.68M	USD	2 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-651.89M	USD	2 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$132.51M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-694.91M	USD	1 Quarter
Net income	`ProfitLoss`	$971.11M	USD	1 Quarter
Net income	`ProfitLoss`	$812.71M	USD	2 Qtrs
Net income	`ProfitLoss`	$1.16B	USD	2 Qtrs
Net income	`ProfitLoss`	$434.00M	USD	1 Quarter
Net loss (income) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.26M	USD	1 Quarter
Net loss (income) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.60M	USD	2 Qtrs
Net loss (income) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$9.76M	USD	2 Qtrs
Net loss (income) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$10.83M	USD	1 Quarter
Net income attributable to AmerisourceBergen Corporation	`NetIncomeLoss`	$435.27M	USD	1 Quarter
Net income attributable to AmerisourceBergen Corporation	`NetIncomeLoss`	$810.11M	USD	2 Qtrs
Net income attributable to AmerisourceBergen Corporation	`NetIncomeLoss`	$960.28M	USD	1 Quarter
Net income attributable to AmerisourceBergen Corporation	`NetIncomeLoss`	$1.15B	USD	2 Qtrs
Basic (usd per share)	`EarningsPerShareBasic`	$3.96	USD	2 Qtrs
Basic (usd per share)	`EarningsPerShareBasic`	$4.68	USD	1 Quarter
Basic (usd per share)	`EarningsPerShareBasic`	$5.58	USD	2 Qtrs
Basic (usd per share)	`EarningsPerShareBasic`	$2.12	USD	1 Quarter
Diluted (usd per share)	`EarningsPerShareDiluted`	$4.64	USD	1 Quarter
Diluted (usd per share)	`EarningsPerShareDiluted`	$3.91	USD	2 Qtrs
Diluted (usd per share)	`EarningsPerShareDiluted`	$5.54	USD	2 Qtrs
Diluted (usd per share)	`EarningsPerShareDiluted`	$2.10	USD	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	205.69M	shares	2 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	204.80M	shares	2 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	204.92M	shares	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	205.37M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	207.31M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	207.06M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	207.06M	shares	2 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	207.29M	shares	2 Qtrs
Cash dividends declared per share of common stock (usd per share)	`CommonStockDividendsPerShareDeclared`	$0.88	USD	2 Qtrs
Cash dividends declared per share of common stock (usd per share)	`CommonStockDividendsPerShareDeclared`	$0.82	USD	2 Qtrs
Cash dividends declared per share of common stock (usd per share)	`CommonStockDividendsPerShareDeclared`	$0.44	USD	1 Quarter
Cash dividends declared per share of common stock (usd per share)	`CommonStockDividendsPerShareDeclared`	$0.42	USD	1 Quarter

Cash Flow Statement 78 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$971.11M	USD	1 Quarter
Net income	`ProfitLoss`	$812.71M	USD	2 Qtrs
Net income	`ProfitLoss`	$1.16B	USD	2 Qtrs
Net income	`ProfitLoss`	$434.00M	USD	1 Quarter
Depreciation, including amounts charged to cost of goods sold	`Depreciation`	$154.68M	USD	2 Qtrs
Depreciation, including amounts charged to cost of goods sold	`Depreciation`	$143.60M	USD	2 Qtrs
Amortization, including amounts charged to interest expense	`AdjustmentForAmortization`	$54.68M	USD	2 Qtrs
Amortization, including amounts charged to interest expense	`AdjustmentForAmortization`	$66.56M	USD	2 Qtrs
Provision for credit losses	`ProvisionForDoubtfulAccounts`	$22.14M	USD	2 Qtrs
Provision for credit losses	`ProvisionForDoubtfulAccounts`	$6.86M	USD	2 Qtrs
Provision (benefit) for deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-21.57M	USD	2 Qtrs
Provision (benefit) for deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$141.60M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$45.76M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$67.11M	USD	2 Qtrs
LIFO (credit) expense	`InventoryLIFOReservePeriodCharge`	$-46.65M	USD	2 Qtrs
LIFO (credit) expense	`InventoryLIFOReservePeriodCharge`	$37.13M	USD	2 Qtrs
Impairment of PharMEDium assets	`AssetImpairmentCharges`	-	USD	2 Qtrs
Impairment of PharMEDium assets	`AssetImpairmentCharges`	$361.65M	USD	2 Qtrs
Impairment of PharMEDium assets	`AssetImpairmentCharges`	-	USD	1 Quarter
Impairment of PharMEDium assets	`AssetImpairmentCharges`	$223.65M	USD	1 Quarter
Other, net	`OtherNoncashIncomeExpense`	$11.31M	USD	2 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$-36.87M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$193.77M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.05B	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$152.36M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$314.29M	USD	2 Qtrs
Income taxes receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$693.63M	USD	2 Qtrs
Income taxes receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$-157.14M	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-18.64M	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.58M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-292.56M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.40B	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-17.58M	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-21.79M	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-145.86M	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-287.59M	USD	2 Qtrs
Accrued litigation liability	`IncreaseDecreaseInAccruedEstimatedLitigationLiability`	$13.78M	USD	2 Qtrs
Accrued litigation liability	`IncreaseDecreaseInAccruedEstimatedLitigationLiability`	-	USD	2 Qtrs
NET CASH PROVIDED BY OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$449.15M	USD	2 Qtrs
NET CASH PROVIDED BY OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$995.71M	USD	2 Qtrs
Capital expenditures	`PaymentsToAcquirePropertyPlantAndEquipment`	$151.61M	USD	2 Qtrs
Capital expenditures	`PaymentsToAcquirePropertyPlantAndEquipment`	$144.38M	USD	2 Qtrs
Cost of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$30.58M	USD	2 Qtrs
Cost of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$162.62M	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-7.16M	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	2 Qtrs
NET CASH USED IN INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-167.80M	USD	2 Qtrs
NET CASH USED IN INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-314.23M	USD	2 Qtrs
Senior notes and other loan borrowings	`ProceedsFromIssuanceOfDebt`	$46.40M	USD	2 Qtrs
Senior notes and other loan borrowings	`ProceedsFromIssuanceOfDebt`	$2.59B	USD	2 Qtrs
Loan repayments	`RepaymentsOfLongTermDebt`	$523.72M	USD	2 Qtrs
Loan repayments	`RepaymentsOfLongTermDebt`	$46.15M	USD	2 Qtrs
Borrowings under revolving and securitization credit facilities	`ProceedsFromLinesOfCredit`	$39.08M	USD	2 Qtrs
Borrowings under revolving and securitization credit facilities	`ProceedsFromLinesOfCredit`	$87.95M	USD	2 Qtrs
Repayments under revolving and securitization credit facilities	`RepaymentsOfLinesOfCredit`	$87.26M	USD	2 Qtrs
Repayments under revolving and securitization credit facilities	`RepaymentsOfLinesOfCredit`	$31.26M	USD	2 Qtrs
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$82.15M	USD	2 Qtrs
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$407.15M	USD	2 Qtrs
Exercises of stock options	`ProceedsFromStockOptionsExercised`	$76.76M	USD	2 Qtrs
Exercises of stock options	`ProceedsFromStockOptionsExercised`	$130.33M	USD	2 Qtrs
Cash dividends on common stock	`PaymentsOfDividendsCommonStock`	$182.37M	USD	2 Qtrs
Cash dividends on common stock	`PaymentsOfDividendsCommonStock`	$170.54M	USD	2 Qtrs
Tax withholdings related to restricted share vesting	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$23.53M	USD	2 Qtrs
Tax withholdings related to restricted share vesting	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$9.59M	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-3.41M	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-589.00K	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$-510.16M	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$1.91B	USD	2 Qtrs
INCREASE IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$317.74M	USD	2 Qtrs
INCREASE IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$2.04B	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.69B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.60B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.37B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.64B	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.69B	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.60B	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.37B	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.64B	USD	Point-in-time

Stockholders Equity 48 line items

Line Item	Tag	Value	Unit	Period
Cash dividends (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$0.82	USD	2 Qtrs
Cash dividends (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$0.44	USD	1 Quarter
Cash dividends (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$0.88	USD	2 Qtrs
Cash dividends (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$0.42	USD	1 Quarter
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.07B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-839.64M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.99B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.71B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-102.78M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-511.55M	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$971.11M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$812.71M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$1.16B	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$434.00M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-55.84M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-4.22M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-30.37M	USD	2 Qtrs
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$39.94M	USD	2 Qtrs
Cash dividends	`DividendsCommonStockCash`	$87.45M	USD	1 Quarter
Cash dividends	`DividendsCommonStockCash`	$91.26M	USD	1 Quarter
Cash dividends	`DividendsCommonStockCash`	$182.37M	USD	2 Qtrs
Cash dividends	`DividendsCommonStockCash`	$170.54M	USD	2 Qtrs
Exercises of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$72.11M	USD	1 Quarter
Exercises of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$56.64M	USD	1 Quarter
Exercises of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$76.76M	USD	2 Qtrs
Exercises of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$130.33M	USD	2 Qtrs
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$14.39M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$18.79M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$67.11M	USD	2 Qtrs
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$45.76M	USD	2 Qtrs
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$82.15M	USD	2 Qtrs
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$262.62M	USD	1 Quarter
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$392.39M	USD	2 Qtrs
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$20.20M	USD	1 Quarter
Employee tax withholdings related to restricted share vesting	`EmployeeTaxWithholdingsRelatedToRestrictedShareVesting`	$-11.00K	USD	1 Quarter
Employee tax withholdings related to restricted share vesting	`EmployeeTaxWithholdingsRelatedToRestrictedShareVesting`	$23.53M	USD	2 Qtrs
Employee tax withholdings related to restricted share vesting	`EmployeeTaxWithholdingsRelatedToRestrictedShareVesting`	$9.59M	USD	2 Qtrs
Employee tax withholdings related to restricted share vesting	`EmployeeTaxWithholdingsRelatedToRestrictedShareVesting`	$281.00K	USD	1 Quarter
Other	`StockholdersEquityOther`	$207.00K	USD	1 Quarter
Other	`StockholdersEquityOther`	$184.00K	USD	1 Quarter
Other	`StockholdersEquityOther`	$1.09M	USD	2 Qtrs
Other	`StockholdersEquityOther`	$538.00K	USD	2 Qtrs
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.07B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-839.64M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.99B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.71B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-102.78M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-511.55M	USD	Point-in-time

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$971.11M	USD	1 Quarter
Net income	`ProfitLoss`	$812.71M	USD	2 Qtrs
Net income	`ProfitLoss`	$1.16B	USD	2 Qtrs
Net income	`ProfitLoss`	$434.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$39.94M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-55.86M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-30.41M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-4.22M	USD	1 Quarter
Other	`OtherComprehensiveIncomeOtherNetOfTax`	$15.00K	USD	1 Quarter
Other	`OtherComprehensiveIncomeOtherNetOfTax`	$34.00K	USD	2 Qtrs
Other	`OtherComprehensiveIncomeOtherNetOfTax`	-	USD	1 Quarter
Other	`OtherComprehensiveIncomeOtherNetOfTax`	-	USD	2 Qtrs
Total other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-55.84M	USD	1 Quarter
Total other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-4.22M	USD	1 Quarter
Total other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-30.37M	USD	2 Qtrs
Total other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$39.94M	USD	2 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$429.79M	USD	1 Quarter
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$915.27M	USD	1 Quarter
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.13B	USD	2 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$852.65M	USD	2 Qtrs
Comprehensive loss (income) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-6.70M	USD	1 Quarter
Comprehensive loss (income) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$68.00K	USD	1 Quarter
Comprehensive loss (income) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$234.00K	USD	2 Qtrs
Comprehensive loss (income) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$2.96M	USD	2 Qtrs
Comprehensive income attributable to AmerisourceBergen Corporation	`ComprehensiveIncomeNetOfTax`	$849.69M	USD	2 Qtrs
Comprehensive income attributable to AmerisourceBergen Corporation	`ComprehensiveIncomeNetOfTax`	$1.13B	USD	2 Qtrs
Comprehensive income attributable to AmerisourceBergen Corporation	`ComprehensiveIncomeNetOfTax`	$436.49M	USD	1 Quarter
Comprehensive income attributable to AmerisourceBergen Corporation	`ComprehensiveIncomeNetOfTax`	$915.20M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.